Psybio Therapeau Stock Price, News & Analysis

PSYBF OTC Link

Company Description

PsyBio Therapeutics Corp (PSYBF) is an intellectual property-driven biotechnology company focused on developing novel, bespoke, psycho-targeted therapeutics to enhance mental and neurological health. With recent government approval to manufacture biosynthetic tryptamines, including their lead compound PsyBio-11142, the company is poised to advance to human clinical trials. PsyBio's bio-medicinal chemistry approach involves utilizing psychoactive compounds as templates for developing precursors and analogs, with ongoing research in naturally occurring tryptamines found in hallucinogenic mushrooms and other sources. The company's leadership role in the industry is underscored by its commitment to scientific advancements and therapeutic development.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$935.8K

Market Cap

130.6M

Shares outstanding

Latest News

View All

July 21, 2023

31.11%

PsyBio Therapeutics Awarded Approval to Manufacture Biosynthetic Tryptamines at Scale

October 11, 2021

6.84%

PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

conferences

July 14, 2021

2.10%

PsyBio Therapeutics Announces Uplisting to OTCQB Venture Market

SEC Filings

View All

No SEC filings available for Psybio Therapeau.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Loading short interest data...

Days to Cover History

Last 12 Months

Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Psybio Therapeau (PSYBF)?

The current stock price of Psybio Therapeau (PSYBF) is $0.000001 as of December 22, 2025.

What is the market cap of Psybio Therapeau (PSYBF)?

The market cap of Psybio Therapeau (PSYBF) is approximately 935.8K. Learn more about what market capitalization means .

What is PsyBio Therapeutics Corp focused on?

PsyBio is dedicated to developing unique, psycho-targeted therapeutics to potentially enhance mental and neurological health.

What recent achievement has PsyBio made?

PsyBio recently received government approval to manufacture biosynthetic tryptamines, including their lead compound PsyBio-11142.

What is PsyBio's approach to therapeutic development?

PsyBio utilizes a bio-medicinal chemistry approach, using psychoactive compounds as templates to develop precursors and analogs for potential therapeutic use.

What is PsyBio's research focus?

PsyBio's research involves naturally occurring tryptamines found in hallucinogenic mushrooms and other sources, exploring their potential for therapeutic applications.

How does PsyBio demonstrate leadership in the industry?

PsyBio's commitment to scientific advancements and the development of psycho-targeted therapeutics underscores its leadership role in the biotechnology industry.